Advanced Cancer Survival: Is More Treatment the Answer?

  • 📰 Medscape
  • ⏱ Reading Time:
  • 27 sec. here
  • 23 min. at publisher
  • 📊 Quality Score:
  • News: 87%
  • Publisher: 55%

Lung Cancer News

Lung Carcinoma,Cancer Of The Lung,Palliative Care

Patients with advanced cancer do not have longer survival rates when treated in practices that prioritize systemic care in the last 2 weeks of life.

Patients with metastatic or advanced cancer treated in practices that have high rates of giving systemic care in the last 2 weeks of life do not have longer survival rates than patients in practices that have low rates of such care.may help reassure oncologists that giving systemic anticancer therapy at the most advanced stages of cancer will not improve the patient's life, the authors wrote.

But the metric has been criticized because it focuses only on people who died and not people who lived longer because they benefited from the systemic therapy, the authors wrote. This study included not just chemotherapy, as some other studies have, but targeted therapies and immunotherapies as well. Dr Adelson said some think that the newer drugs might change the prognosis at end of life. But this study shows"even those drugs are not helping patients to survive with very advanced cancer," she said.

Source: Healthcare Press (healthcarepress.net)

Lung Carcinoma Cancer Of The Lung Palliative Care Cancer Malignant Neoplasia Carcinoma Malignant Neoplasm Advanced Cancer Biologic Therapy Biologics Small Cell Lung Cancer Small-Cell Lung Cancer Oat Cell Lung Cancer SCLC Malignant Kidney Neoplasm Renal Cell Cancer RCC - Renal Cell Carcinoma Cancer Of The Kidney Renal Cell Carcinoma RCC Targeted Therapy

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 386. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Abemaciclib Combo Improves Survival in Advanced Breast CancerAbemaciclib plus fulvestrant improved progression-free survival in certain patients with advanced breast cancer, new data showed.
Source: Medscape - 🏆 386. / 55 Read more »

Does Early Palliative Care via Telehealth Work in Advanced Cancer?Early palliative care can be delivered successfully and efficiently using telehealth in patients with advanced lung cancer and could improve patient access to this evidence-based care.
Source: Medscape - 🏆 386. / 55 Read more »

Pfizer's drug for advanced lung cancer shows promising long-term trial resultsThe company's medicine helped patients live longer without seeing their cancer progress, as most of them experienced that benefit for over five years.
Source: CNBC - 🏆 12. / 72 Read more »

A Benefit to Add-On Abemaciclib in Advanced Breast Cancer?Adding abemaciclib to an aromatase inhibitor improved overall survival in HR+/HER2− advanced breast cancer, but the benefit was not statistically significant, according to final trial results.
Source: Medscape - 🏆 386. / 55 Read more »

Green algae-made microrobots help increase lung cancer survival rate by 40%The new frontier of cancer treatment: microrobots made from green algae deliver medication directly to infected lungs in mice.
Source: IntEngineering - 🏆 287. / 63 Read more »

Moderna, Merck say vaccine improved survival in patients with deadly skin cancerNearly 75% of patients who took the cancer vaccine and Keytruda were alive without any signs or symptoms of their cancer returning at the 2½-year mark.
Source: NBCLA - 🏆 319. / 59 Read more »